Natasha Dyal, MD

Treatment with 400 mg once-monthly injectable aripiprazole demonstrates efficacy in preventing recurrence of mood episodes in patients with bipolar I.

Transition from a once-monthly formulation of a long-acting, injectable paliperidone palmitate to a once-every-3-month formulation treatment regimen in patients with schizophrenia demonstrated increased adherence to antipsychotic medication.